1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Positron-Emission Tomography: new trials by email Literature Review of Positron-Emission Tomography trials Research Report on Positron-Emission Tomography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies 68Ga-FAP-CHX - Tumor, Positron-Emission Tomography | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Fujian Medical University | 50 | 2022-05-01 | 2023-09-21 |
| ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors ⁸⁹Zr-Df-IAB22M2C - Positron-Emission Tomography, Metastatic Solid Tumors | Phase 2 | Completed | ImaginAb, Inc. | 52 | 2018-12-18 | 2024-07-09 |
Neoplasms (1)
68Ga-FAPI (1) · Fluorodeoxyglucose F18 (1)
First Affiliated Hospital of Fujian Medical University (1) · ImaginAb, Inc. (1)
China (1) · United States (1)
Ron Korn, MD, PhD (1) · Weibing Miao, MD (1)